Fujifilm Group － Business Overview

Transcript

Fujifilm Group － Business Overview Jan. 2017 FORWARD-LOOKING STATEMENTS Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management’s current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties, and other factors. Accordingly, actual results may differ materially from those projected due to various factors. 1. Business Fields of Fujifilm Group Others Global services 10% Photo imaging 71% Optical Device & Electronic Imaging products d t 17% Production services Imaging Solutions 14% Office printers 16% Document Solutions 29% ¥353.3 ¥353 3 billion （14%） Healthcare 44% FY2016/3 Revenue ¥2,491.6 billion ¥1,174.1 billion （47%） Office products 43% Information Solutions FPD materials ¥964.2 billion （39%） 10% Industrial products and Electronic materials Recording media Graphic systems 5% 11% Highly functional materials 30% 2 2. Wave of Digitalization and Management Reform Demand for photographic film dropped rapidly after its peak in 2000 due to digitalization Core technologies created from its photographic business ●Making film bases Expanding and uniformly flattening molten materials in units of micrometers to make an optically warp warp-free, free thin film *Index Index based on an aggregate demand of 100 in FY2001/3 100 Rapid Decline 80 ●Making photosensitive emulsions 60 Designing functional materials at the nanometer level 40 Peak 20 ●Coating functional materials on base films 0 FY1994/3 FY2001/3 FY2011/3 About 20μm Boldly diversified its business utilizing its high technological capabilities cultivated through photographic business High-speed simultaneous coating of multiple uniform layers Section of color film (after development) ●Photographing with a camera Ensuring the high-quality design and manufacture of lenses, hardware, and systems ●Developing and printing photographs Controlling chemical reactions ti tto ensure proper images and building appropriate systems 3 2. Wave of Digitalization and Management Reform Developing wide-range of businesses utilizing core technologies cultivated through its photographic business Concentrated management resources into the selected six priority business fields Capital Investment R&D M&A Investment 4 3. Priority business fields Business Portfolio Three fields that drive growth among priority business fields Healthcare Highly Functional Materials Document ・ Consists of medical systems, life sciences (cosmetics), pharmaceuticals, and regenerative medicine. ・ Consists of flat panel display (FPD) materials and industrial products & electronics materials ・ Maintain stable profit in FPD materials. Create a number of new businesses with high profitability in highly functional materials fields ・ A Fuji Xerox business that offers multifunction devices, printers, and solution services ・ Realize stable profit growth in medical systems. Aim to launch new drugs around 2018 ・ Strengthen device sales in emerging countries and promote solution services in developed countries Support growth by stable profit base Large-scale businesses such as Graphic systems and Photo imaging 5 4. Imaging Solutions Revenue in FY2016/3 Photo Imaging ¥249.9 billion ・ Main p products are p photographic g p p paper p ((color p paper) p ) and the instax instant camera C l paper Color Expand business by reinforcing sales off such h high-value-added hi h l dd d printing i ti services as Photobook I t instant Instax i t t camera ・ Sales are expanding worldwide triggered by the boom in sales in Asia. ・ Unit sales are breaking records. Year Album Optimized business structure to meet the decline in demand for photographic film and created a structure that can generate stable profit 6 4. Imaging Solutions Optical Device & Electronic Imaging Products Revenue in FY2016/3 ¥103.4 billion Digital Cameras Optical Device & Electronic Imaging Utilizing the synergies between Optical Device and Electronic Imaging business Expand sales by appealing FUJINON brand brand’s s advanced lens technologies and imaging technologies. Strengthen sales of the products such as security lenses, high-end digital cameras, where the market growth is expected 7 4. Imaging Solutions Optical Device & Electronic Imaging (Digital camera) ・ Focus on high-end models “X Series” and differentiated products ・ Realize high image quality that surpasses single single-lens lens reflex cameras by premium mirrorless cameras X Series （premium compact cameras) X Series （mirrorless cameras) Differentiated products （water-proof, long-zoom) F Focus on high-end hi h d models, d l mainly i l XS Series i and d iinterchangeable t h bl llenses 8 5. Information Solutions Revenue in FY2016/3 Healthcare ¥423.5 billion Medical Systems: y Diagnosis g Endoscopes X-ray diagnostic imaging systems (FCR/DR/film) Medical-use Medical use picture archiving and communications systems (PACS) Life Sciences : Prevention Ultrasound Pharmaceuticals: Treatment Regenerative Medicine : Treatment Pharmaceuticals Functional cosmetics Autologous cultured epidermis Supplements Autologous Cultured cartilage Generate stable profit in medical systems Launch unique new drugs in pharmaceuticals in the medium term 9 5. Information Solutions Healthcare (Medical Systems) X-ray Imaging Diagnostic Equipment Services Medical IT Ultrasound Endoscopes In Vitro Diagnosis ・ Growth fields are medical-use picture archiving and communications systems (medical IT), endoscopes, ultrasound, and In Vitro Diagnosis. － Improve cost competitiveness by cost reduction and minimizing fixed costs in equipment － Increase I market k t share h for f materials, t i l making ki it a cash h cow b business i － Strengthen sales in emerging countries ・ Achieved OPM 10% in FY2016/3 ahead of the plan 10 5. Information Solutions Healthcare (Medical Systems) Medical IT ・ SYNAPSE medical-use di l picture i t archiving hi i and d communications i ti systems t (PACS) attain tt i the th No.1 N 1 share h iin JJapan. ・ Gain a position as owner of big data by utilizing advantage of open platform. ・ Provide various applications, which support image diagnosis by analyzing accumulated data. Patient information Electronic  medical records Medical IT systems t integrate to i t t images i and information at hospitals CT/MRI Data accumulated in systems of Fujifilm is expanding IVD Other hospitals Oth h it l and clinics in regions Regional Partnership Ultrasound equipment Endoscopes X‐ray imaging  diagnostic equipment 3D image analysis system content-based retrieval system for supporting image diagnosis SYNAPSE VINCENT SYNAPSE Case Match Realize double-digit sales growth by responding to market demand for efficiency in medical treatment 11 5. Information Solutions Healthcare (Medical Systems) Endoscopes Launch differentiated products with high value-added, value added, that utilizes image processing technology cultivated through the photographic business and thinner sizing technology etc. - Transnasal T l endoscopes d - Endoscope systems with laser light sources - Double-balloon endoscopes Transnasal Endoscopes Transnasal endoscope T Two types t off laser l light li ht source Image processing technology Former endoscope Surface of mucous membrane Lessen the patient’s discomfort by streamlining superfine transnasal endoscope Mucous membrane Blood vessel Endoscope system with laser light sources By fusing Fujifilm’s image processing technology, the visibility of the diseased part improved. Realize double-digit sales growth by expanding sales of differentiated products 12 5. Information Solutions Healthcare (Medical Systems) Ultrasound ・ In March 2012, Fujifilm acquired SonoSite, the U.S.-based leading manufacturer of bedside and point-of-care (POC) ultrasound diagnostic equipment. 2014 Group Synergies 2011 Further Ultrasound growth ¥740.0 billion ・ High image processing technology ・ Sales network in Asia ・ Strong in diagnosis market ・ Rich knowh /k how/knowledge l d ・ Over half of its sales in North America ・ Strong in POC market ¥650.0 billion Portable ¥110.0 billion Portable ¥140.0 billion IHS 2014 Sonosite iViz, Develop new products utilizing group synergies Strengthen both St th sales l utilizing tili i sales l channels h l off b th companies A tablet type ultrasound diagnostic equipment Maintain double-digit double digit sales growth and aim to achieve top share in portable ultrasound diagnostic equipment market, where high growth is expected 13 5. Information Solutions Healthcare (Medical Systems) X-ray film ・ Global demand is gradually declining and Fujifilm is focusing on increasing its market share. In emerging countries, demand for film used for output proceeds steadily. y X-ray diagnostic imaging systems ・ FCR: Fuji Computed Radiography. Fujifilm was the first to develop this medical equipment (launched in 1983) and has a high market share. There are only four manufacturers of CR equipment in the world. Radiography. Several manufacturers are entering this field and competition is intensifying intensifying. ・ DR: Digital Radiography Accumulate image information Digitization Check on PC monitor Imaging plate (IP) IP cassettes X-ray exposure Read the film Film output Realized significant X-ray diagnostic imaging system cost reductions of by reviewing its equipment design and parts procurement costs. Improved profitability. 14 5. Information Solutions Healthcare (Pharmaceuticals) ・ Built a business foundation via M&A of business firms ・ Conduct sales of existing drugs from consolidated subsidiaries, subsidiaries mainly from Toyama Chemical Chemical, and R&D for new drugs Business foundation by group companies Biopharmaceuticals Low-molecular drugs FUJIFILM RI Pharma Toyama Chemical One of two specialty pharmaceutical companies in Japan that develops, manufactures, and markets radiopharmaceuticals and medicines A top-class top class pharmaceuticals company for infectious disease medicines in Japan Conduct development and manufacture FUJIFILM Finechemicals Fi h i l FUJIFILM Pharma Sales company that offers brand-name drugs and generics Manufacture of raw materials FUJIFILM Diosynth Biotechnologies A contract manufacturing organization (CMO) for biopharmaceuticals and manufacturing base. Fujifilm R&D Pharmaceuticals & Healthcare Research Laboratories Conducts R&D of new drugs, using Fujifilm’s core technologies 15 5. Information Solutions Healthcare (Pharmaceuticals) 5. Information Solutions Healthcare ea t ca e ((Pharmaceuticals) a aceut ca s) Development code Therapeutic category Formu lation T-705 Anti-influenza drug Oral T-3811 Quinolone synthetic antibacterial drug T-2307 T-817MA T-4288 Bio ITK 1 ITK-1 Region Development stage Japan Approved U.S.A. PⅢ Oral China Submitted an application for permission Antifungal drug Injecti on U.S.A. PⅠcompleted USA U.S.A. PⅡ Alzheimer's disease drug Oral Undertaking g clinical trials with the Alzheimer’s Disease Cooperative Study Japan PⅡ Engaging in the search and identification of biomarkers with the CiRA of Kyoto University PⅢ Already launched as Geninax in Japan Oral Japan Castration resistant prostate cancer drug Castration-resistant J Japan PⅢ Japan PⅠcompleted U.S.A. Preparing for PⅡ Promoting clinical trial with the MD Anderson Cancer Center USA U.S.A. PⅠ Promoting clinical trial with the MD Anderson Cancer Center Europe /Japan Preparing for PⅠ U.S.A. PⅠ Europe E /Japan Preparing for PⅠ Japan PⅡ Oral U.S.A. Preparing for PⅠ Oral U.S.A. Europe /Japan Non clinical trial Oral FF-10502 Advanced/recurrent pancreatic/ovarian cancer drug Injecti on Advanced/recurrent non-small cell lung/pancreatic cancer drug (armed antibody) F-1311 Diagnostic drug for prostate cancer (Radiopharmaceuticals) FF-10101 Acute Myeloid Leukemia (AML) drug FF-10102 Under clinical trials utilizing subsidy from the U.S. Department of Defense Injecti j on Relapsed or Refractory myelodysplastic syndrome drug FF-21101 Approved in March 2014 (AVIGAN®) Fluoroketolide antibacterial drug FF-10501 Bio Note Autoimmune disease drug Injecti on Promoting clinical trial with the MD Anderson Cancer Center Note: FKB327 (a biosimilar of adalimumab) of FUJIFILM KYOWA KIRIN Biologics (FKB), an equity method affiliated company is under phaseⅢclinical trial in U.S.A. and other countries. FKB238 (a biosimilar of bevacizumab ) of JV between FKB and AstraZeneca is under phase Ⅲclinical trial in U.S., Europe and other region. 17 5. Information Solutions Healthcare ea t ca e ((Regenerative ege e at e Medicine) ed c e) The Three Key Components for Regenerative Medicine Cell Scaffold (recombinant peptide) Cell Culture Medium/ Cytokine Contributing to the elevation of regenerative medicine business to the industrial stage while leveraging synergies between the three companies companies. •Expansion of drugs discovery support business that utilize iPS cells •Commercialization of cell therapy py (Age-related macular degeneration, Parkinson‘s disease, heart failure, etc.) 18 5. Information Solutions Healthcare (Life Sciences) ・ Utilizing technologies cultivated through its photographic business, Fujifilm started its cosmetics business in 2006. ・ Fujifilm expanded its lineups, such as the ASTALIFT series, the Lunamer series with women in their 20s and 30s as its main target. ・ The ASTALIFT series is a total healthcare brand that includes base makeup, supplements, and h i care products hair d t iin addition dditi tto skincare ki products. d t ASTALIFT series Lunamer series Supplement Differentiate itself from competitors and offer its original products supported by science, utilizing proprietary technologies 19 5. Information Solutions Healthcare (Life Sciences) ■ Link between p photographic g p technologies g and cosmetics The major component of photo film is collagen, the same as that of the skin The antioxidant technology of photo film is used Without antioxidant technology The nano-technology for photographic exposure and color development is used Conventional New Nano-technology Nano-technology Collagen g 25 years after With antioxidant technology Collagen Oxidation Nano--technology Nano Main ingredient of photo film Causes color fading of photos Used for exposure and color development of photos Forms about 70% of dermis Causes skin blemishes and aging Improves permeability and absorption of ingredients 20 5. Information Solutions Highly Functional Materials (Flat (F lat Panel Display (FPD) Materials) Revenue in FY2016/3 ¥95.9 billion ■ Our functional materials which are used in LCDs Our Products Front FUJITAC Protective film for polarizer PVA (stretched PVA doped with iodine) Compensation film Polarizer WV/VA/IPS film Glass Substrate ガラス基板 ガラス基板 Color Filter Transer Film LCD Cell Color filter transferred on to the glass substrate Liquid Crystal Layer TFT Glass Substrate Compensation p film PVA Protective film for polarizer Polarizer WV/VA/IPS film FUJITAC Back Light g ■ Differences in LCD modes Contrast Viewing angle Efficiency of light emission Manufacturing cost TN mode VA mode IPS mode ○ ◎ △ △ ○ (Using △→○ (U i WV fil film)) × ○ (Using ×→○ (U i retardation d i fil film)) ○ ◎ (Using ○→◎ (U i Z Z-TAC) TAC) ◎ ○ ○ Low Middle High ⇒ To cover weak points or improve quality, p films” “compensation are used 21 5. Information Solutions Highly g y Functional Materials (Flat (F lat Panel Display (FPD) Materials) FUJITAC ・ Protective film for polarizer. Used regardless of any difference in LCD mode. WV film ・ A compensation film that widens the viewing angle in TN mode. Fujifilm has 100% market share. VA film ・ A film used for the polarizer in VA mode to control the inflection of light for better viewing angles and contrast. IPS film ・ A film used for the polarizer in IPS mode to contain tint fluctuations when the screen （Z-TAC） is viewed diagonally diagonally. ■ Diagram showing volume of panel shipments and main films used by application FUJITAC WV (TN) VA Z-TAC (IPS) ● ● Partly used ● TVs ● Monitors ● ● Notebook PCs ● Partly used Partly used Small and medium-sized displays (tablet PCs/smartphones) ● Partly used ● (as of Jan.-Dec.2015, internal investigation) 22 5. Information Solutions Highly g y Functional Materials (Flat (F lat Panel Display (FPD) Materials) For TVs ・ Screens for LCD panels continues to expand owing to such factors as the increase in the size of TVs ・ Promote sales of VA/IPS film and FUJITAC ・ Introduced low-shrinkage Z-TAC to meet the needs of low moisture permeability for IPS mode For small and medium-sized displays ・ Reinforce sales of super-thin 25μm FUJITAC and Z-TAC for smartphones, where the demand is expected to grow, and for tablet PC Depreciation costs have been reduced as large capital investments have almost run their course. Maintain high profitability as a cash cow business 23 5. Information Solutions Highly Functional Materials Revenue in FY2016/3 (Industrial Products, Electronics Materials & Others) ¥106.1 billion Industrial Products New business Existing business ・ Non-destructive testing equipment and materials (Industrial use X (Industrial-use X-ray ray films films, digital X X-ray ray imaging system) ・ Microfilters ・ PRESCALE (pressure measurement film) ・ Sensor film for touch panels ・ Realize high transparency and flexibility by patterning with silver on a transparent PET base film . ・ Low resistance and can be adjusted to medium- to large-sized touch panels. Enables simplified manufacturing process. process ・ Have a role in protecting the reverse side of outdoor solar cells from rain, UV, and other damaging elements. ・ Three times more durable than general PET,, and have acquired g q certification in a module base Continuously create new high-value-added businesses/products th t can utilize that tili Fujifilm’s F jifil ’ technologies t h l i and dh have hi high h profitability, fit bilit mainly in the growth fields of touch panels and environment/energy 24 5. Information Solutions Highly Functional Materials (Industrial Products, Electronics Materials & Others) Electronics Materials Offer products used when manufacturing semiconductors IC chip Cross section Wirings are bonded within the multi-layer structure Wiring Ph t Photoresist i t CMP slurry l A material indispensable for manufacturing ultra-small circuit patterns on semiconductors. It is used during the process where the circuit pattern is printed onto a wafer. An abrasive material used to precisely planarize substrate that has various materials in its circuit structure, like metal or dielectrics G B R G Image sensor consists of red (R), green (G), and blue (B) Image sensor C l resist Color i t A photo-sensitive coloring material for manufacturing micro color filters, used in image sensors. E Expand d sales l b by offering ff i lleading-edge di d products, d t lleveraging i F Fujifilm’s jifil ’ wide-ranging id i product portfolio and stable supply capabilities 25 5. Information Solutions Recording Media Revenue in FY2016/3 ¥46.6 billion ・ Since Fujifilm developed professional-use videotapes in 1959, the Company has offered products with high performance and high reliability to tape drive manufacturers throughout the world. Magnetic tapes for data storage Professional--use videotapes Professional Fujifilm’s Fujifilm s magnetic tapes for data storage with barium ferrite particles (BaFe), which were developed by Fujifilm’s proprietary technologies, are achieving a high reputation in the market. ・ ・ ・ ・ ・ Large capacity Long archival life Highly cost effectiveness Recording stability Energy-saving Mainly used by broadcasting stations Further usage in the data archive field is expected, reflecting fl ti th the rapid id iincrease off d data t iin th the world ld and d the popularization of cloud computing. New data archiving service d：ternity Reinforce sales promotion, leveraging original BaFe products 26 5. Information Solutions Revenue in FY2016/3 Graphic Systems ■ Offset printing materials and d equipments i t ・Graphic arts films ・Printing gp plates (conventional plates, CTP （Computer to Plate） plates） ・High productivity ・Suitable for large volume printing such as newspapers and publications ・Mainstream is usage of CTP plate which directly exposes plate, printing data made by computer to printing plate ¥285.0 billion ■Digital printing equipment ■Inkjet heads for industrial-use printers i t ・ Digital inkjet press JetPress series ・Wide-format inkjet systems ・On-demand printing suitable for small print runs. Expect future growth by diversification of market needs ・Suitable for commercial printing such as package printing ・Inkjet heads for industrial-use printers for various purposes as construction materials. ・Development and sales by Dimatix, which was acquired in 2006 Focusing on the growth market of digital printing and inkjet heads for industrial industrial-use use printers while securing stable profit with CTP plates 27 6. Document Solutions Document Revenue in FY2016/3 ¥1,174.1 billion ・ Document solutions is a business conducted by Fuji Xerox. ・ FUJIFILM H Holdings ldi h has a 75% share h off th the stock, t k and d th the restt iis h held ld b by X Xerox C Corporation. ti Products that Fuji Xerox develops and manufactures are also exported to Xerox Corporation. Through Xerox Corporation Fuji Xerox Corporation, offers products globally. Business is operated in cooperation with U.S.-based Xerox Corporation 28 6. Document Solutions Document Japan/Oceania Asia (China) Large enterprises, Government administration offices Medium-tosmall scale enterprises A region where Fuji Xerox is strong Cover by long experience of direct sales Prepare/strengthen dealer networks and aggressively reach the mass retailer market Accelerate mass sales of low-end models that meet local needs to acquire substantial q market share DocuCentre SC2020 Offer solution services that support and resolve management as well as operational issues, which are becoming more diversified and complex complex, from a document viewpoint Continuous measures to reduce costs Expand customer bases in Asia, mainly China, and reinforce solution services in such developed countries as Japan and Oceania by utilizing Fuji Xerox’s Xerox s long experience of direct sales Increase profitability by continuous cost reductions 29 6. Document Solutions Document Office Products Revenue in FY2016/3 ¥505.9 billion ・Offer multifunction devices and consumables for offices. ・Offer a wide range of solution services for document management and mission-critical mission critical operations through software that realizes interoperativity of multifunction devices with various types of operational systems and applications. Revenue in FY2016/3 Office Printers ¥192.0 billion ・Offer small, highly functional, and high image quality color and monochrome laser printers in Japan and the Asia-Oceania region as well as in the European and U.S. markets through OEM supply. 30 6. Document Solutions Document Production Services Revenue in FY2016/3 ¥159 2 billion ¥159.2 ・Offer on-demand printing systems for the digital printing market and continuous feed printers for clients’ mission-critical operations. Offer services that will support operating workflows and marketing communications ・Offer Global Services Revenue in FY2016/3 ¥196 3 billion ¥196.3 billi ・Conclude contracts for the continuous optimization of document-related operating processes or whole value chains, which include the pre and post-procedures of the operating process. Contracts to include services that support the optimization of clients’ overall print environments (M (Managed dP Print i S Service: i MPS) MPS). ・Expand business in the Asia-Oceania region by maximizing synergies with an Australian service provider acquired in FY2013/3. ・Fujij Xerox Service Link Co., Ltd., which took over the document-related business of consolidated subsidiary of Mitsubishi Heavy Industries, Ltd., was included in the consolidation from FY2015/3. 31 Appendix Investor Relations Website FUJIFILM Holdings － Investor Relations http://www.fujifilmholdings.com/en/investors/index.html Earnings Presentations http://www.fujifilmholdings.com/en/investors/ir_events/earnings_presentations/index.html Earnings presentation materials (transcript attached), main responses to queries, and more… IR Events Materials http://www.fujifilmholdings.com/en/investors/ir_events/business_presentations/index.html Conference materials, business presentation materials, and more… What Kind of Company p y is Fujifilm? j http://www.fujifilmholdings.com/en/investors/guidance/index.html 32